About UNC iTOP
The UNC iTOP training program focuses on training clinicians, basic scientists, and MD-PhD candidates in clinical/translational disease-based research. We recognize that optimal care of patients afflicted with cancer can only be achieved through a multi-disciplinary approach. Our major focus is to educate future researchers from a variety of backgrounds in the approaches and tools that will be needed to perform tissue-based research.
UNC iTOP provides research training support for up to two years, training physicians-in-training in translational oncology bench research and immersing PhDs in a clinical/translational environment. The curriculum includes relevant introductory coursework as well as mini-rotations (see Sample of iTOP Activities) to provide trainees with an in depth perspective on the different aspects of tissue-based research.
Follow us at @ItopUNC 
News
-
2024 Lineberger Cancer Research Center Trainee Day
Current and past iTOP trainees presented during the poster session at 2024 Trainee Day. Hannah Trembath, MD- past iTOP trainee Emily Kounlavong and Zackary Schrank -current iTOP trainees Dr. Robert Ferris, MD, PhD- Director, and Kristen Gilley- current iTOP trainee
-
Congratulations Emily Kounlavong!
Congratulation’s Emily on receiving a cash prize for the People’s Choice Poster Session Awards at the 49th LCCC Trainee Day on October 1, 2024. Basic Science – Emily Kounlavong, BS, Deciphering the Role of Cancer Associated Fibroblast Mediated Bladder Cancer Progression
-
Congratulations to Hannah Trembath, MD!
Congratulations to Hannah Trembath, MD, UNC General Surgery resident for her mini-oral presentation at the Americas Hepato-Pancreato-Biliary Association 2024 meeting!
-
UNC Pathobiology Symposium at the NC Botanical Garden
Our predoctoral trainee, Emily Kounlavong, presented their research at the UNC Pathobiology Symposium on October 13, 2023. The symposium was held at the NC Botanical Garden in Chapel Hill, NC. Poster title: Enhanced detection and characterization of targetable EGFR and ERBB2 exon 20 insertion mutations in urothelial carcinoma.
Events
There are no upcoming events at this time.